Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 753,102 | 893,369 | 573,610 | 485,040 | 472,255 |
| Marketable Securities | 219,054 | 217,193 | 218,277 | 198,885 | 205,237 |
| TOTAL | $1,021,027 | $1,126,587 | $806,263 | $697,950 | $689,503 |
| Non-Current Assets | |||||
| PPE Net | 23,682 | 24,029 | 23,972 | 5,675 | 5,747 |
| Other Non-Current Assets | 35,241 | 36,342 | 36,824 | 25,367 | 25,824 |
| TOTAL | $58,923 | $60,371 | $60,796 | $31,042 | $31,571 |
| Total Assets | $1,079,950 | $1,186,958 | $867,059 | $728,992 | $721,074 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,224 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 10,781 | 8,082 | 12,061 | 14,016 | 7,019 |
| Accrued Expenses | 29,211 | 37,548 | 42,749 | 22,454 | 21,752 |
| TOTAL | $51,249 | $50,625 | $59,849 | $41,472 | $33,882 |
| Non-Current Liabilities | |||||
| Long Term Debt | 149,375 | 148,921 | 99,147 | 98,813 | N/A |
| Other Non-Current Liabilities | 14,271 | 15,283 | 16,280 | 17,262 | 18,219 |
| TOTAL | $163,646 | $164,204 | $115,427 | $116,075 | $18,219 |
| Total Liabilities | $214,895 | $214,829 | $175,276 | $157,547 | $52,101 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 165,314 | 165,027 | 142,825 | 142,264 | 113,667 |
| Common Shares | 16 | 16 | 14 | 11 | 11 |
| Retained earnings | -1,516,996 | -1,396,142 | -1,284,187 | -1,176,146 | -1,065,289 |
| Other shareholders' equity | -137 | 475 | 496 | 252 | 241 |
| TOTAL | $865,055 | $972,129 | $691,783 | $571,445 | $668,973 |
| Total Liabilities And Equity | $1,079,950 | $1,186,958 | $867,059 | $728,992 | $721,074 |